LT - Mazindol en tant que seul principe actif ou en combinaison avec du fer pour le traitement du déficit de l`attention/hyperactivité
EN - Mazindol alone or in combination with iron for the treatment of attention-deficit/hyperactivity disorder
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/4188 |
|
|
|
A61K 33/26 |
|
|
|
A61P 25/26 |
|
European patent
| (11) |
Number of the document |
2564872 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
12189703.7 |
|
Date of filing the European patent application |
2007-04-11 |
| (97) |
Date of publication of the European application |
2013-03-06 |
| (45) |
Date of publication and mention of the grant of the patent |
2020-06-10
|
| (46) |
Date of publication of the claims translation |
|
Priority applications
| (30) |
Number |
Date |
Country code |
|
0603197 |
2006-04-11
|
FR |
Inventors
| (72) |
Konofal, Eric, FR
|
Grantee
| (73) |
NLS Pharmaceutics AG,
Alter Postplatz 2, 6370 Stans,
CH
|
Title
| (54) |
Mazindol en tant que seul principe actif ou en combinaison avec du fer pour le traitement du déficit de l`attention/hyperactivité |
| |
Mazindol alone or in combination with iron for the treatment of attention-deficit/hyperactivity disorder |
